Mo1518: EFFICACY OF THE TREAT-TO-TARGET APPROACH IN MODIFYING DISEASE COURSE WITH USTEKINUMAB IN PATIENTS WITH MODERATETO-SEVERE CROHN’S DISEASE: RESULTS FROM THE STARDUST TRIAL | Publicación